NURO [NASD]
NeuroMetrix, Inc.
Index- P/E- EPS (ttm)-0.68 Insider Own0.40% Shs Outstand7.76M Perf Week9.94%
Market Cap13.24M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float7.66M Perf Month12.74%
Income-4.70M PEG- EPS next Q- Inst Own14.70% Short Float / Ratio3.35% / 0.47 Perf Quarter-45.71%
Sales8.20M P/S1.61 EPS this Y35.70% Inst Trans0.92% Short Interest0.26M Perf Half Y-59.40%
Book/sh3.13 P/B0.57 EPS next Y- ROA-18.80% Target Price- Perf Year-74.82%
Cash/sh2.79 P/C0.63 EPS next 5Y15.00% ROE-20.40% 52W Range1.35 - 7.41 Perf YTD-64.74%
Dividend- P/FCF- EPS past 5Y76.20% ROI-9.80% 52W High-76.11% Beta2.28
Dividend %- Quick Ratio12.20 Sales past 5Y-7.30% Gross Margin70.00% 52W Low31.11% ATR0.13
Employees23 Current Ratio12.80 Sales Q/Q-4.80% Oper. Margin-59.80% RSI (14)50.29 Volatility5.61% 9.61%
OptionableNo Debt/Eq0.00 EPS Q/Q-93.60% Profit Margin-57.50% Rel Volume0.42 Prev Close1.66
ShortableYes LT Debt/Eq0.00 EarningsOct 20 BMO Payout- Avg Volume545.73K Price1.77
Recom2.00 SMA207.35% SMA50-13.25% SMA200-46.33% Volume229,238 Change6.63%
Oct-20-17Reiterated H.C. Wainwright Buy $10 → $3
Jun-28-16Initiated Rodman & Renshaw Buy $4.50
Sep-11-15Initiated Maxim Group Buy $2
Feb-27-12Initiated Dawson James Buy $3
Nov-08-22 09:00AM
Nov-03-22 09:00AM
Oct-20-22 07:00AM
Oct-12-22 03:47PM
Sep-25-22 08:26AM
09:00AM Loading…
Sep-01-22 09:00AM
Jul-21-22 07:00AM
Jul-14-22 11:32AM
Jun-28-22 09:00AM
May-19-22 09:00AM
Apr-26-22 07:00AM
Apr-19-22 09:00AM
Apr-18-22 06:35AM
Feb-24-22 02:21PM
09:00AM
07:00AM Loading…
Jan-27-22 07:00AM
Jan-20-22 12:10PM
Jan-18-22 11:54AM
09:00AM
08:28AM
Jan-10-22 09:00AM
Jan-05-22 09:00AM
Oct-21-21 07:00AM
Oct-20-21 09:00AM
08:50AM
Oct-14-21 09:00AM
Oct-07-21 12:01PM
07:01AM
Oct-06-21 06:42PM
Oct-05-21 09:00AM
07:05AM Loading…
Aug-30-21 07:05AM
Aug-27-21 12:58PM
12:04PM
11:09AM
07:08AM
04:44AM
Aug-13-21 03:24PM
Jul-26-21 09:00AM
Jul-22-21 07:00AM
05:46AM
Jul-21-21 04:35AM
Jul-20-21 02:54PM
01:37PM
11:14AM
11:04AM
09:00AM
Jul-15-21 09:00AM
Jun-15-21 09:00AM
Jun-09-21 11:20AM
08:00AM
Apr-22-21 07:00AM
06:45AM
Apr-15-21 01:00PM
Jan-28-21 07:00AM
05:45AM
Jan-27-21 03:22AM
Jan-22-21 11:05AM
Oct-22-20 07:00AM
Oct-15-20 11:00AM
Sep-22-20 07:00AM
Sep-21-20 01:00PM
Sep-04-20 07:00AM
Sep-01-20 01:00PM
Aug-20-20 02:11PM
Aug-10-20 10:00AM
Jul-23-20 07:00AM
Jul-16-20 03:14PM
Jul-09-20 01:00PM
Jun-25-20 01:00PM
Jun-10-20 06:30PM
01:00PM
Apr-23-20 07:00AM
06:00AM
Apr-16-20 01:30PM
11:00AM
Apr-15-20 09:17AM
Apr-10-20 01:43PM
Mar-11-20 11:00AM
Mar-05-20 12:14PM
Feb-25-20 01:58PM
Feb-20-20 09:19AM
Jan-30-20 04:43AM
Jan-27-20 07:00AM
Jan-22-20 10:43AM
Jan-17-20 12:49PM
Jan-06-20 01:15PM
06:32AM
Dec-06-19 09:25AM
Nov-18-19 11:50AM
Nov-13-19 09:07AM
Oct-25-19 08:45AM
Oct-18-19 07:07AM
Oct-17-19 07:00AM
Oct-15-19 11:00AM
Oct-10-19 11:00AM
Jul-21-19 11:30PM
Jul-18-19 07:00AM
06:00AM
Jul-15-19 09:15AM
Jul-11-19 01:15PM
NeuroMetrix, Inc., a healthcare company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, China, the Middle East, and Mexico. Its primary marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system, a platform for the performance of nerve conduction studies. The company offers its products to managed care organizations, endocrinologists, podiatrists, and primary care physicians; occupational health, primary care, internal medicine, orthopedic, and hand surgeons; and pain medicine physicians, neurologists, physical medicine and rehabilitation physicians, and neurosurgeons. NeuroMetrix, Inc. was incorporated in 1996 and is headquartered in Woburn, Massachusetts.